BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 29324312)

  • 1. The hypoxia-responsive long non-coding RNAs may impact on the tumor biology and subsequent management of breast cancer.
    Kapinova A; Kubatka P; Zubor P; Golubnitschaja O; Dankova Z; Uramova S; Pilchova I; Caprnda M; Opatrilova R; Richnavsky J; Kruzliak P; Danko J
    Biomed Pharmacother; 2018 Mar; 99():51-58. PubMed ID: 29324312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Status of Long Non-Coding RNAs in Human Breast Cancer.
    Cerk S; Schwarzenbacher D; Adiprasito JB; Stotz M; Hutterer GC; Gerger A; Ling H; Calin GA; Pichler M
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27608009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.
    Malih S; Saidijam M; Malih N
    Tumour Biol; 2016 Feb; 37(2):1479-85. PubMed ID: 26662315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNAs in regulation of human breast cancer.
    Wang G; Liu C; Deng S; Zhao Q; Li T; Qiao S; Shen L; Zhang Y; Lü J; Meng L; Liang C; Yu Z
    Brief Funct Genomics; 2016 May; 15(3):222-6. PubMed ID: 26582840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional significance of long non-coding RNAs in breast cancer.
    Vikram R; Ramachandran R; Abdul KS
    Breast Cancer; 2014 Sep; 21(5):515-21. PubMed ID: 25038622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs differential expression in breast cancer subtypes: What do we know?
    Mathias C; Zambalde EP; Rask P; Gradia DF; de Oliveira JC
    Clin Genet; 2019 May; 95(5):558-568. PubMed ID: 30614523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication.
    Wang J; Ye C; Xiong H; Shen Y; Lu Y; Zhou J; Wang L
    Oncotarget; 2017 Jan; 8(3):5508-5522. PubMed ID: 27732939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-regulated lncRNAs in cancer.
    Chang YN; Zhang K; Hu ZM; Qi HX; Shi ZM; Han XH; Han YW; Hong W
    Gene; 2016 Jan; 575(1):1-8. PubMed ID: 26341058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncoding RNAs in breast cancer.
    Lo PK; Wolfson B; Zhou X; Duru N; Gernapudi R; Zhou Q
    Brief Funct Genomics; 2016 May; 15(3):200-21. PubMed ID: 26685283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
    Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
    Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNAs as prognostic markers in human breast cancer.
    Liu H; Li J; Koirala P; Ding X; Chen B; Wang Y; Wang Z; Wang C; Zhang X; Mo YY
    Oncotarget; 2016 Apr; 7(15):20584-96. PubMed ID: 26942882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
    Bradford JR; Cox A; Bernard P; Camp NJ
    PLoS One; 2016; 11(9):e0163238. PubMed ID: 27685983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling in and out: long-noncoding RNAs in tumor hypoxia.
    Kuo TC; Kung HJ; Shih JW
    J Biomed Sci; 2020 May; 27(1):59. PubMed ID: 32370770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNAs: An emerging powerhouse in the battle between life and death of tumor cells.
    Xiong XD; Ren X; Cai MY; Yang JW; Liu X; Yang JM
    Drug Resist Updat; 2016 May; 26():28-42. PubMed ID: 27180308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying the crosstalk of dysfunctional pathways mediated by lncRNAs in breast cancer subtypes.
    Wang L; Li J; Zhao H; Hu J; Ping Y; Li F; Lan Y; Xu C; Xiao Y; Li X
    Mol Biosyst; 2016 Mar; 12(3):711-20. PubMed ID: 26725846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNAs (lncRNAs) in triple negative breast cancer.
    Wang Q; Gao S; Li H; Lv M; Lu C
    J Cell Physiol; 2017 Dec; 232(12):3226-3233. PubMed ID: 28138992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers.
    Panoutsopoulou K; Avgeris M; Scorilas A
    Expert Rev Mol Diagn; 2018 Nov; 18(11):963-979. PubMed ID: 30338716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel long non-coding RNAs in triple-negative breast cancer.
    Shen X; Xie B; Ma Z; Yu W; Wang W; Xu D; Yan X; Chen B; Yu L; Li J; Chen X; Ding K; Cao F
    Oncotarget; 2015 Aug; 6(25):21730-9. PubMed ID: 26078338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovering DNA methylation patterns for long non-coding RNAs associated with cancer subtypes.
    Ma X; Yu L; Wang P; Yang X
    Comput Biol Chem; 2017 Aug; 69():164-170. PubMed ID: 28501295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.